Recently, in order to create a quality culture of integrity, transparency and pursuit of excellence, maintain the quality system of continuous improvement and improve the quality management level of the company, Shanghai Junshi Biosciences Co.Ltd(688180) the first quality month of “win in quality” held in Shanghai Lingang Holdings Co.Ltd(600848) production base was successfully held.
It is understood that the activity lasted for one month, and five series of activities were planned and designed by young employees in the front line, including “big coffee lecture”, “interesting quality PK competition”, “professional terminology battle”, “quality event detective” and “quality star selection”. Through diversified activities, Shanghai Junshi Biosciences Co.Ltd(688180) the participation of employees is improved, and the quality management awareness of employees is deepened and improved in many aspects and angles.
Shanghai Junshi Biosciences Co.Ltd(688180) said that quality and compliance are everyone’s responsibility. The activities of quality month broke the “wall” between departments and let more employees participate in the quality improvement process. “The soul of quality lies in ingenuity”, actively embrace the quality culture, let the quality culture be naturally interpreted in daily work and details, and make it become Shanghai Junshi Biosciences Co.Ltd(688180) every employee’s imperceptible quality consciousness.
At present, there are 45 products on the R & D pipeline of Shanghai Junshi Biosciences Co.Ltd(688180) . In order to meet the production demand of drugs on the R & D pipeline, two monoclonal antibody production bases have been built in Wujiang, Suzhou and Shanghai Lingang Holdings Co.Ltd(600848) , with a total fermentation capacity of 34500 liters. With the rapid expansion of production capacity, Shanghai Junshi Biosciences Co.Ltd(688180) has also established a life-cycle quality management system covering drug R & D, production, sales and other links.
